Urinary nitric oxide in newborns with infections

Area of Science:

• Neonatalogy
• Infectious Diseases
• Biochemistry

Background:

• Neonatal sepsis presents diagnostic challenges, leading to high morbidity and mortality.
• Early diagnosis is crucial for effective treatment of infections in newborns.
• Urinary nitric oxide (NO) is explored as a potential biomarker for neonatal infections.

Purpose of the Study:

• To evaluate the utility of urinary nitric oxide (NO) levels in diagnosing neonatal sepsis.
• To compare NO levels in infected newborns versus age-matched healthy controls.
• To determine the sensitivity and specificity of urinary NO for infection detection.

Main Methods:

• Inclusion of newborns aged 1-7 days and 8-30 days with suspected infections and healthy controls.
• Assay of urine NO levels using Sievers NOA chemiluminescence.
• Correction of NO levels for urine creatinine and comparison between groups.

Main Results:

• Higher urinary NO levels were observed in infected newborns (1-7 days: 80.25±60.68; 8-30 days: 81.78±40.43 µmol/mg creatinine) compared to controls (1-7 days: 25.45±19.35; 8-30 days: 36.99±24.58 µmol/mg creatinine).
• The test demonstrated high specificity (95% for 1-7 days, 93% for 8-30 days) but moderate sensitivity (50% for both groups).
• NO levels were similar in culture-proven and clinical sepsis, and higher than in other infections.

Conclusions:

• Urinary NO levels are elevated in infected newborns, offering a potentially useful diagnostic marker.
• The test is quick, easy to perform, and shows good specificity.
• Low sensitivity necessitates combining urinary NO measurement with other biomarkers for accurate neonatal sepsis diagnosis.